125 related articles for article (PubMed ID: 469372)
1. Reversal of skeletal resistance to parathyroid hormone in uremia by vitamin D metabolites: evidence for the requirement of 1,25(OH)2D3 and 24,25(OH)2D3.
Massry SG; Tuma S; Dua S; Goldstein DA
J Lab Clin Med; 1979 Jul; 94(1):152-7. PubMed ID: 469372
[TBL] [Abstract][Full Text] [Related]
2. Skeletal resistance to the calcemic action of parathyroid hormone in uremia: role of 1,25 (OH)2 D3.
Massry SG; Stein R; Garty J; Arieff AI; Coburn JW; Norman AW; Friedler RM
Kidney Int; 1976 Jun; 9(6):467-74. PubMed ID: 940279
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P
Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
[TBL] [Abstract][Full Text] [Related]
5. Effect of parathyroid hormone and uremia on peripheral nerve calcium and motor nerve conduction velocity.
Goldstein DA; Chui LA; Massry SG
J Clin Invest; 1978 Jul; 62(1):88-93. PubMed ID: 659642
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
Magliola L; Anast CS; Forte LR
Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783
[TBL] [Abstract][Full Text] [Related]
7. Resistance to parathyroid hormone in renal failure: role of vitamin D metabolites.
Somerville PJ; Kaye M
Kidney Int; 1978 Sep; 14(3):245-54. PubMed ID: 723151
[TBL] [Abstract][Full Text] [Related]
8. Effect of 1,25(OH)2D3 and 24,25(OH)2D3 on experimental rickets.
Kraft D; Offermann G; Steldinger R; Gawlik D
Res Commun Chem Pathol Pharmacol; 1979 Dec; 26(3):571-80. PubMed ID: 523788
[TBL] [Abstract][Full Text] [Related]
9. A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content.
Takahashi F; Finch JL; Denda M; Dusso AS; Brown AJ; Slatopolsky E
Am J Kidney Dis; 1997 Jul; 30(1):105-12. PubMed ID: 9214408
[TBL] [Abstract][Full Text] [Related]
10. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
Brickman AS; Coburn JW; Friedman GR; Okamura WH; Massry SG; Norman AW
J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
[TBL] [Abstract][Full Text] [Related]
11. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
[TBL] [Abstract][Full Text] [Related]
12. Effects in vivo of vitamin D metabolites and 17 beta-estradiol on parathyroid hormone-dependent formation of adenosine 3',5'-monophosphate in rat bone.
Marcus R; Orner FB; Brickman AS
Endocrinology; 1980 Nov; 107(5):1593-9. PubMed ID: 6253269
[TBL] [Abstract][Full Text] [Related]
13. The role of phosphorus in the genesis of azotemic osteodystrophy.
Somerville PJ; Kaye M
Prog Biochem Pharmacol; 1980; 17():228-35. PubMed ID: 6894195
[TBL] [Abstract][Full Text] [Related]
14. Role of 1,25-dihydroxyvitamin D on the skeletal resistance to parathyroid hormone.
Galceran T; Martin KJ; Morrissey JJ; Slatopolsky E
Kidney Int; 1987 Dec; 32(6):801-7. PubMed ID: 3430963
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
Lambert PW; Hollis BW; Bell NH; Epstein S
J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
[TBL] [Abstract][Full Text] [Related]
16. Selective deficiency of 1,25-dihydroxycholecalciferol. A cause of isolated skeletal resistance to parathyroid hormone.
Metz SA; Baylink DJ; Hughes MR; Haussler MR; Robertson RP
N Engl J Med; 1977 Nov; 297(20):1084-90. PubMed ID: 198661
[TBL] [Abstract][Full Text] [Related]
17. Hypocalcemic effect of 24R, 25-dihydroxyvitamin D3 in rats.
Maeda Y; Yamato H; Katoh T; Orimo H
In Vivo; 1987; 1(6):347-50. PubMed ID: 2979802
[TBL] [Abstract][Full Text] [Related]
18. Regulation of calcitonin gene transcription by vitamin D metabolites in vivo in the rat.
Naveh-Many T; Silver J
J Clin Invest; 1988 Jan; 81(1):270-3. PubMed ID: 2891728
[TBL] [Abstract][Full Text] [Related]
19. Effect of 24,25(OH)2D3 on PTH levels and bone histology in dogs with chronic uremia.
Olgaard K; Finco D; Schwartz J; Arbelaez M; Teitelbaum S; Avioli L; Klahr S; Slatopolsky E
Kidney Int; 1984 Dec; 26(6):791-7. PubMed ID: 6335904
[TBL] [Abstract][Full Text] [Related]
20. 1,25 dihydroxycholecalciferol treatment of uraemic rats after high magnesium feeding.
Binswanger U; Schiffl H; Huggler M; Becker C
Proc Eur Dial Transplant Assoc; 1980; 17():563-8. PubMed ID: 6894642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
